BioWorld-International-2007-11-14
Antisense Pharma Gets $39.5M For Antisense Glioma Product
Antisense Pharma Gets $39.5M For Antisense Glioma Product
Antisense Pharma GmbH raised 27 million (US$39.5 million) in a third investment round funded solely by MIG AG, which also was the only investor in its 18 million funding round two years ago. (BioWorld International)

